 She continued to develop the compound as a potential cancer therapeutic at Georgetown Lombardi Comprehensive Cancer Center.From 2002 to 2005 she specialized in intellectual property and technology transfer at the Ludwig Institute for Cancer Research in New York City, where she filed patents for vaccines and licensed them to biotechnology and pharmaceutical companies.In 2006, she founded Foligo Therapeutics, a biotech company with a mission of developing ways to improve the detection and treatment of ovarian cancer.